As an initial approach to assessing the potential effect of dn-ATF5 on survivin expression, we transfected PC3 prostate tumor cells with a previously described construct expressing GFP-FLAG-dn-ATF523 and determined total survivin levels by western immunoblotting after 3 days (Fig. 1a). Here, BIRC5 is linked to prostate neoplasm.